journal article·2020-02-12

Helix Self-Assembly Behavior of Amino Acid-Modified Camptothecin Prodrugs and Its Antitumor Effect

Zhaopei Guo, Lin Lin, Kai Hao, Dianwei Wang, Feng Liu, Pingjie Sun, Haiyang Yu, Zhaohui Tang, Meiwan Chen, Huayu Tian, Xuesi Chen

Publisher page

Abstract

For effective antitumor treatment, it is important to increase the water solubility of hydrophobic antitumor drugs and improve their cell absorption efficiency and nuclear transmission capacity. Here, we use endogenous hydrophilic arginine to modify camptothecin (CPT) to increase its water solubility. Surprisingly, the modified CPT can self-assemble into helical nanofibers through intermolecular π-π stacking and hydrophilic-hydrophobic interactions. Prodrug-based nanofibers were better endocytosed into the nucleus than their nonassembled CPT. Moreover, in vivo, such nanofibers had a longer blood circulation time and a better ability to accumulate in the tumor site. Further, we found that the cationic nanofibers can be combined with the anionic cisplatin-polyglutamic acid through electrostatic interaction to achieve a combined antitumor effect. This provides a new idea for achieving more effective cancer chemotherapy effects.
Source: openalex_inverted_index · Quality: baseline

Research context

OpenAlex topics: Advanced biosensing and bioanalysis techniques · Supramolecular Self-Assembly in Materials · Supramolecular Chemistry and Complexes

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Key Laboratory of Polymer Ecomaterials, Changchun Institute of Applied Chemistry, Chinese Academy of Sciences, Changchun 130022, China

State Key Laboratory of Quality Research in Chinese Medicine, Institute of Chinese Medical Sciences, University of Macau, Taipa, Macao 999078, China

Jilin Biomedical Polymers Engineering Laboratory, Changchun 130022, China

Funding

National Natural Science Foundation of China · National program for support of Top-notch young professionals, Jilin province science and technology development program · National Science and Technology Major Projects for Major New Drugs Innovation and Development

References (52)

Show source-provided references
1. 10.1016/0022-2836(88)90462-710.1016/0022-2836(88)90462-7 ↗
2. Jaxel C. · Cancer Res. · 1989 · 49 · 1465
3. 10.1038/nrc197710.1038/nrc1977 ↗
4. Satchi-Fainaro R. · 2006 · 1
5. 10.1021/jm00027a00510.1021/jm00027a005 ↗
6. 10.1021/jm00123a03810.1021/jm00123a038 ↗
7. 10.1111/j.1349-7006.2000.tb00980.x10.1111/j.1349-7006.2000.tb00980.x ↗
8. 10.1016/j.ijpharm.2014.01.04110.1016/j.ijpharm.2014.01.041 ↗
9. 10.1159/00044340410.1159/000443404 ↗
10. 10.1093/jnci/85.4.27110.1093/jnci/85.4.271 ↗
11. 10.1021/ja505212y10.1021/ja505212y ↗
12. 10.1039/c6tb00612d10.1039/c6tb00612d ↗
13. 10.1002/anie.20161075310.1002/anie.201610753 ↗
14. 10.1016/0169-409x(95)00031-210.1016/0169-409x(95)00031-2 ↗
15. 10.1007/s11426-010-4144-310.1007/s11426-010-4144-3 ↗
16. Lin L. · Acta Polym. Sin. · 2017 · 2 · 321
17. 10.1021/ja513034e10.1021/ja513034e ↗
18. 10.1039/c2cs15327k10.1039/c2cs15327k ↗
19. 10.1021/ja311598310.1021/ja3115983 ↗
20. 10.1039/c5nr03259h10.1039/c5nr03259h ↗
21. 10.1039/c7bm00791d10.1039/c7bm00791d ↗
22. 10.1021/acsnano.7b0821910.1021/acsnano.7b08219 ↗
23. 10.1002/anie.20180198410.1002/anie.201801984 ↗
24. Yokoyama M. · Cancer Res. · 1991 · 51 · 3229
25. 10.1016/j.addr.2010.05.00810.1016/j.addr.2010.05.008 ↗
26. 10.1111/j.1349-7006.2009.01103.x10.1111/j.1349-7006.2009.01103.x ↗
27. 10.1039/c2cs15344k10.1039/c2cs15344k ↗
28. 10.1016/j.biomaterials.2016.10.01610.1016/j.biomaterials.2016.10.016 ↗
29. 10.1039/c7cs00521k10.1039/c7cs00521k ↗
30. 10.1039/c3cc49453e10.1039/c3cc49453e ↗
31. 10.7150/thno.1542010.7150/thno.15420 ↗
32. 10.1007/s12274-015-0945-110.1007/s12274-015-0945-1 ↗
33. 10.1021/jacs.6b1232210.1021/jacs.6b12322 ↗
34. 10.1021/ja909475m10.1021/ja909475m ↗
35. 10.1021/acs.bioconjchem.5b0051310.1021/acs.bioconjchem.5b00513 ↗
36. 10.1039/c6cc07595a10.1039/c6cc07595a ↗
37. 10.1016/j.nantod.2015.11.00310.1016/j.nantod.2015.11.003 ↗
38. 10.1021/acs.chemmater.9b0043910.1021/acs.chemmater.9b00439 ↗
39. 10.1021/acs.chemmater.7b0004710.1021/acs.chemmater.7b00047 ↗
40. 10.1002/adma.20120293210.1002/adma.201202932 ↗
41. 10.1158/0008-5472.can-09-326710.1158/0008-5472.can-09-3267 ↗
42. 10.1093/rb/rbv01110.1093/rb/rbv011 ↗
43. 10.1016/j.colsurfb.2018.02.05410.1016/j.colsurfb.2018.02.054 ↗
44. 10.1038/nrd169110.1038/nrd1691 ↗
45. 10.1038/nrc74910.1038/nrc749 ↗
46. 10.1166/jbn.2016.215210.1166/jbn.2016.2152 ↗
47. 10.1039/c4ra08225g10.1039/c4ra08225g ↗
48. 10.1002/prot.2086310.1002/prot.20863 ↗
49. 10.1021/jacs.6b0625310.1021/jacs.6b06253 ↗
50. 10.1021/jm901029n10.1021/jm901029n ↗
51. 10.1002/anie.20140644210.1002/anie.201406442 ↗
52. 10.1021/ja502011g10.1021/ja502011g ↗